Review
Open access
Sep 2026
Efficacy of Curcumin in Neurodegenerative Diseases: From Pharmacokinetic Barriers to Advanced Delivery Systems
Background and Objectives: The main neurodegenerative diseases (NDs)—Alzheimer’s disease (AD), Parkinson’s disease (PD), multiple sclerosis (MS), and amyotrophic lateral sclerosis (ALS)—represent a growing global health burden with no available disease-modifying therapies. Curcumin, a polyphenol from Curcuma longa, is...
Alejandra Castelló-Guillen, Marta Garrido-Reig, Jordi Caplliure-Llopis et al.
· Pharmaceuticals · 0 citations